Citadel Advisors’s Baird Medical Investment Holdings BDMD Stock Holding History
Bought
Maintained
Sold
Other funds holding BDMD
XT
WAM
CIAM
Citadel Advisors's BDMD Position: Q2 2026 in Review
Citadel Advisors opened a new position in Baird Medical Investment Holdings (BDMD) in Q2 2026: 54,895 shares worth $63.1K. The stake represents ﹤0.01% of the portfolio and ranks #12999 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in BDMD as recently as Q4 2025.
Citadel Advisors first reported a position in BDMD in Q3 2025 and has held it in 3 quarters since. The position peaked at $153K in Q4 2025. 10 funds tracked by Wall St. Rank hold BDMD as of Q2 2026.
- Citadel Advisors held 54,895 shares of Baird Medical Investment Holdings worth $63.1K as of Q2 2026.
- Baird Medical Investment Holdings was a new Citadel Advisors position in Q2 2026.
- Baird Medical Investment Holdings made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #12999 holding.
- Citadel Advisors first reported a position in Baird Medical Investment Holdings in Q3 2025 and has held it in 3 quarters since.
- Citadel Advisors's Baird Medical Investment Holdings position peaked at $153K in Q4 2025.
- 10 funds tracked by Wall St. Rank held Baird Medical Investment Holdings as of Q2 2026.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.